Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naive patients with Crohn's disease with propensity score adjustment: two-year maintenance phase results from the prospective VEDO-IBD study
JOURNAL OF CROHNS & COLITIS(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要